A carregar...
Flow Cytometry Quality Requirements for Monitoring of Minimal Disease in Plasma Cell Myeloma
Current therapeutic approaches for plasma cell myeloma (PCM) attain an overall survival of more than 6 years for the majority of newly diagnosed patients. However, PFS and OS are the only accepted FDA clinical endpoints for demonstrating drug efficacy before they can be become frontline therapeutic...
Na minha lista:
| Publicado no: | Cytometry B Clin Cytom |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404813/ https://ncbi.nlm.nih.gov/pubmed/26201282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.b.21276 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|